Literature DB >> 8574590

The role of medullary ischemia in acute renal failure.

S N Heyman1, S Fuchs, M Brezis.   

Abstract

The introduction of new techniques for the determination of renal parenchymal oxygenation and intrarenal microcirculation has elucidated some important aspects in the pathophysiology of acute renal failure (ARF). Data accumulated over the last decade with these techniques, together with improved morphologic evaluation of the kidney, indicate that medullary damage may play a pivotal role in various forms of acute and chronic renal hypoxic and toxic insults. The outer medulla functions normally under hypoxic conditions, as a result of limited regional oxygen supply and high oxygen consumption for urinary concentration. Outer medullary oxygenation is critically balanced by mechanisms designed to adjust oxygen demand and supply, and their insufficiency may lead to ARF with hypoxic medullary damage. In this article, we outline our current concept of the physiologic control of medullary oxygenation and review the clinical conditions that predispose to hypoxic medullary damage, including rhabdomyolysis, hypercalcemia, or the exposure to endotoxin, nonsteroidal anti-inflammatory drugs, radiologic contrast agents, cyclosporine, FK506, and amphothericin. We shall indicate a possible role for medullary oxygen insufficiency in clinical conditions known to predispose to ARF, such as preexisting renal disease, diabetes mellitus, hypertension, atherosclerosis, effective volume depletion, urinary obstruction, or aging, and suggest potential strategies to preserve medullary oxygenation and integrity.

Entities:  

Mesh:

Year:  1995        PMID: 8574590

Source DB:  PubMed          Journal:  New Horiz        ISSN: 1063-7389


  13 in total

1.  In vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor.

Authors:  Eva Csongradi; Trinity Vera; John M Rimoldi; Rama S V Gadepalli; David E Stec
Journal:  Pharmacol Res       Date:  2010-03-23       Impact factor: 7.658

2.  Evaluation of intrarenal oxygenation by BOLD MRI at 3.0 T.

Authors:  Lu-Ping Li; Anthony T Vu; Belinda S Y Li; Eugene Dunkle; Pottumarthi V Prasad
Journal:  J Magn Reson Imaging       Date:  2004-11       Impact factor: 4.813

Review 3.  Early management of the severely injured patient.

Authors:  M P Colvin; M T Healy; G S Samra
Journal:  J R Soc Med       Date:  1998-01       Impact factor: 5.344

4.  Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using BOLD MRI.

Authors:  S M Tumkur; A T Vu; L P Li; L Pierchala; P V Prasad
Journal:  Kidney Int       Date:  2006-03-29       Impact factor: 10.612

Review 5.  An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure.

Authors:  M K Dishart; J A Kellum
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

6.  Evaluation of intrarenal oxygenation at 3.0 T using 3-dimensional multiple gradient-recalled echo sequence.

Authors:  Santosh Tumkur; Anthony Vu; Luping Li; Pottumarthi V Prasad
Journal:  Invest Radiol       Date:  2006-02       Impact factor: 6.016

Review 7.  Blood oxygen level-dependent MR imaging of the kidneys.

Authors:  Lu-Ping Li; Sarah Halter; Pottumarthi V Prasad
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

8.  The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation.

Authors:  Samuel N Heyman; Zohair Hanna; Taher Nassar; Ahuva Shina; Sa'ed Akkawi; Marina Goldfarb; Seymour Rosen; Abd-Al Roof Higazi
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

9.  The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence.

Authors: 
Journal:  Crit Care       Date:  1997       Impact factor: 9.097

10.  Dopamine Use in Intensive Care: Are We Ready to Turn it Down?

Authors:  Geremia Zito Marinosci; Edoardo De Robertis; Giuseppe De Benedictis; Ornella Piazza
Journal:  Transl Med UniSa       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.